华邦健康
(002004)
| 流通市值：94.65亿 | | | 总市值：99.59亿 |
| 流通股本：18.82亿 | | | 总股本：19.80亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 9,085,988,424.34 | 5,945,032,088.09 | 2,820,969,309.75 | 11,664,669,783.79 |
| 营业收入 | 9,085,988,424.34 | 5,945,032,088.09 | 2,820,969,309.75 | 11,664,669,783.79 |
| 二、营业总成本 | 8,097,647,440.81 | 5,353,287,909.61 | 2,540,921,781.44 | 10,758,061,028.78 |
| 营业成本 | 5,723,444,074.29 | 3,787,991,698.41 | 1,773,938,403.36 | 7,683,859,359.93 |
| 税金及附加 | 102,300,552.54 | 64,633,224.23 | 31,911,391.88 | 129,149,704.88 |
| 销售费用 | 967,485,254.24 | 679,396,280.23 | 300,584,294.93 | 1,021,953,508.93 |
| 管理费用 | 836,811,849.43 | 514,113,021.04 | 272,086,044.31 | 1,277,742,199.4 |
| 研发费用 | 281,993,931.22 | 197,547,094.89 | 107,103,304.5 | 375,319,013.67 |
| 财务费用 | 185,611,779.09 | 109,606,590.81 | 55,298,342.46 | 270,037,241.97 |
| 其中:利息费用 | 224,523,762.21 | 153,155,858.38 | 73,001,380.1 | 349,974,105.54 |
| 其中:利息收入 | 39,159,580.01 | 27,473,174.78 | 13,272,465.01 | 69,659,912.52 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 4,449,568.59 | 2,734,211.26 | 622,260.29 | 3,097,277.73 |
| 加:投资收益 | 21,877,855.3 | 45,604,511.88 | 12,700,521.39 | -172,079,130.75 |
| 资产处置收益 | 16,992,889.78 | 12,005,319.65 | 2,978,628.75 | 3,752,750.93 |
| 资产减值损失(新) | -7,999,859.19 | -8,094,961.01 | 104,819.07 | -929,742,732.37 |
| 信用减值损失(新) | -25,795,699.89 | -18,666,523.13 | -5,682,820.22 | -33,629,022.75 |
| 其他收益 | 63,204,742.36 | 41,348,739.98 | 19,541,583.62 | 94,557,094.96 |
| 四、营业利润 | 1,061,070,480.48 | 666,675,477.11 | 310,312,521.21 | -127,435,007.24 |
| 加:营业外收入 | 36,664,665.35 | 32,436,279.1 | 1,122,512.21 | 12,929,819.42 |
| 减:营业外支出 | 10,394,891.6 | 8,160,387.23 | 1,791,342.25 | 46,001,995.43 |
| 五、利润总额 | 1,087,340,254.23 | 690,951,368.98 | 309,643,691.17 | -160,507,183.25 |
| 减:所得税费用 | 207,905,855.11 | 141,077,981.82 | 68,845,204.05 | 182,086,373.63 |
| 六、净利润 | 879,434,399.12 | 549,873,387.16 | 240,798,487.12 | -342,593,556.88 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 879,434,399.12 | 549,873,387.16 | 240,798,487.12 | -342,593,556.88 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 611,820,373.56 | 388,455,625.5 | 184,340,340.89 | -298,989,917.1 |
| 少数股东损益 | 267,614,025.56 | 161,417,761.66 | 56,458,146.23 | -43,603,639.78 |
| 扣除非经常损益后的净利润 | 552,241,633.34 | 347,597,224.74 | 170,435,366.02 | -337,852,237.08 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.31 | 0.2 | 0.09 | -0.15 |
| (二)稀释每股收益 | 0.31 | 0.2 | 0.09 | -0.15 |
| 八、其他综合收益 | 24,148,295.85 | 34,835,443.96 | 11,754,995.9 | -36,412,599.46 |
| 归属于母公司股东的其他综合收益 | 11,114,458.08 | 16,380,915.78 | 5,646,710.4 | -17,889,642.46 |
| 九、综合收益总额 | 903,582,694.97 | 584,708,831.12 | 252,553,483.02 | -379,006,156.34 |
| 归属于母公司股东的综合收益总额 | 622,934,831.64 | 404,836,541.28 | 189,987,051.29 | -316,879,559.56 |
| 归属于少数股东的综合收益总额 | 280,647,863.33 | 179,872,289.84 | 62,566,431.73 | -62,126,596.78 |
| 公告日期 | 2025-10-29 | 2025-08-20 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |